Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 3Rectal Neoplasms 2Ovarian Neoplasms 2Breast Neoplasms 2Peritoneal Neoplasms 1Kidney Neoplasms 1Genital Neoplasms, Female 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1

Interventions

Cisplatin 5Paclitaxel 4Fluorouracil 3sodium thiosulfate 2Cytoreduction Surgical Procedures 2veliparib 1vandetanib 1nilotinib 1birinapant 1Surgical Procedures, Operative 1Semaxinib 1Radiotherapy 1Radiation 1Oxaliplatin 1Mitomycin 1Laparoscopy 1Electrocardiography 1Doxorubicin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Peritoneal Neoplasms × Laparoscopy × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡